Axogen Inc vs Constellation Energy Corporation — how do they compare? Axogen Inc trades at $38.7 (market cap $2.06B), while Constellation Energy Corporation trades at $262.76 (market cap $91.57B). The key difference: Constellation Energy Corporation is far larger — about 44.5× Axogen Inc's market cap, and Constellation Energy Corporation pays a 0.67% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | CEG | |
|---|---|---|
Market Cap | $2.06B | $91.57B |
Sector | Technology | Energy |
52-Week High | $46.19 | $403.95 |
52-Week Low | $11.28 | $236.50 |
Enterprise Value | $1.98B | $113.24B |
Dividend Yield | — | 0.67% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Constellation Energy (CEG) trades at $257.57, up 2.46% today, showing strong momentum despite a bearish technical signal. The stock benefits from robust fundamentals with 2025 revenue of $25.53B and net income of $2.32B, supported by a 70% analyst buy rating and consensus price target of $343.50. Recent news highlights CEG's strategic positioning to capitalize on rising AI-driven electricity demand and nuclear power resurgence.
The outlook remains positive with CEG positioned as a key beneficiary of growing electricity demand from AI and data centers. Investment opportunities include strong earnings growth projections and favorable valuation metrics. Risks include execution challenges in capacity expansion and potential regulatory changes affecting utility operations.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Constellation is the largest producer of carbon-free energy in the U.S. and a leading nuclear power plant operator. It provides sustainable electricity to millions of residential, public, and industrial customers.
Read more on CEG →